Published in J Inherit Metab Dis on August 27, 2011
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. Rheumatology (Oxford) (2013) 0.98
Amyloidosis in alkaptonuria. J Inherit Metab Dis (2015) 0.84
Amyloidosis, inflammation, and oxidative stress in the heart of an alkaptonuric patient. Mediators Inflamm (2014) 0.83
NMR-based metabolomics of urine in a mouse model of Alzheimer's disease: identification of oxidative stress biomarkers. J Clin Biochem Nutr (2013) 0.81
Secondary amyloidosis in an alkaptonuric aortic valve. Int J Cardiol (2014) 0.79
The Pigment in Alkaptonuria Relationship to Melanin and Other Coloured Substances: A Review of Metabolism, Composition and Chemical Analysis. JIMD Rep (2015) 0.79
Homogentisate 1,2 dioxygenase is expressed in brain: implications in alkaptonuria. J Inherit Metab Dis (2015) 0.76
Old treatments for new insights and strategies: proposed management in adults and children with alkaptonuria. J Inherit Metab Dis (2015) 0.75
Diagnosis of secondary amyloidosis in alkaptonuria. Diagn Pathol (2014) 0.75
Reduced primary cilia length and altered Arl13b expression are associated with deregulated chondrocyte Hedgehog signaling in alkaptonuria. J Cell Physiol (2017) 0.75
A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem (1976) 903.81
Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med (1967) 16.75
Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol (1990) 6.05
Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun (1976) 5.74
Natural history of alkaptonuria. N Engl J Med (2002) 5.32
The nature of the defect in tyrosine metabolism in alcaptonuria. J Biol Chem (1958) 4.90
Glutathione reductase. Methods Enzymol (1985) 4.80
A highly sensitive silver stain for detecting proteins and peptides in polyacrylamide gels. Anal Biochem (1979) 4.77
Redefining oxidative stress. Antioxid Redox Signal (2006) 4.71
Protein damage and degradation by oxygen radicals. I. general aspects. J Biol Chem (1987) 3.88
The molecular basis of alkaptonuria. Nat Genet (1996) 3.51
Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia (1981) 2.71
S-glutathionylation in protein redox regulation. Free Radic Biol Med (2007) 2.53
Protein damage and degradation by oxygen radicals. II. Modification of amino acids. J Biol Chem (1987) 2.36
Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol (1994) 2.19
Identification of proteins containing cysteine residues that are sensitive to oxidation by hydrogen peroxide at neutral pH. Anal Biochem (2000) 2.17
Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med (2000) 2.15
Aceruloplasminemia: molecular characterization of this disorder of iron metabolism. Proc Natl Acad Sci U S A (1995) 2.01
The extraordinary ligand binding properties of human serum albumin. IUBMB Life (2005) 2.00
Specific detection of quinoproteins by redox-cycling staining. J Biol Chem (1991) 1.97
Oxidation in rheumatoid arthritis. Arthritis Res Ther (2004) 1.96
Protein damage and degradation by oxygen radicals. IV. Degradation of denatured protein. J Biol Chem (1987) 1.94
Covalent modification of amino acid nucleophiles by the lipid peroxidation products 4-hydroxy-2-nonenal and 4-oxo-2-nonenal. Chem Res Toxicol (2002) 1.92
Protein damage and degradation by oxygen radicals. III. Modification of secondary and tertiary structure. J Biol Chem (1987) 1.82
Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal (2008) 1.78
A mutation in apolipoprotein A-I in the Iowa type of familial amyloidotic polyneuropathy. Genomics (1990) 1.74
New developments in ochronosis: review of the literature. Rheumatol Int (2004) 1.66
Cysteine modification by lipid peroxidation products inhibits protein disulfide isomerase. Chem Res Toxicol (2005) 1.61
Variant apolipoprotein AI as a major constituent of a human hereditary amyloid. Biochem Biophys Res Commun (1988) 1.35
Apolipoprotein AI mutation Arg-60 causes autosomal dominant amyloidosis. Proc Natl Acad Sci U S A (1992) 1.35
Extracellular cysteine/cystine redox potential controls lung fibroblast proliferation and matrix expression through upregulation of transforming growth factor-beta. Am J Physiol Lung Cell Mol Physiol (2007) 1.34
Alkaptonuria, ochronosis, and ochronotic arthropathy. Semin Arthritis Rheum (2004) 1.24
Sulfur in human nutrition and applications in medicine. Altern Med Rev (2002) 1.24
Oxidation of homogentisic acid to ochronotic pigment in connective tissue. Biochim Biophys Acta (1969) 1.21
Alkaptonuria--a review of surgical and autopsy pathology. Histopathology (2008) 1.16
Control of extracellular cysteine/cystine redox state by HT-29 cells is independent of cellular glutathione. Am J Physiol Regul Integr Comp Physiol (2007) 1.12
Chronic ochronotic arthritis: clinical, arthroscopic, and pathologic findings. J Rheumatol (2000) 1.11
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology (Oxford) (2010) 1.11
Quinones and glutathione metabolism. Methods Enzymol (2004) 1.07
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol (2010) 1.06
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes. J Cell Biochem (2010) 1.03
Depletion of thiol-containing proteins in response to quinones in Bacillus subtilis. Mol Microbiol (2008) 1.01
Impact of diabetes mellitus on the relationships between iron-, inflammatory- and oxidative stress status. Diabetes Metab Res Rev (2006) 0.99
Increased carbonyl content of proteins in synovial fluid from patients with rheumatoid arthritis. J Rheumatol (1989) 0.99
Studies on ochronosis. II. Studies on benzoquinoneacetic acid, a probale intermediate in the connective tissue pigmentation of alcaptonuria. Arthritis Rheum (1962) 0.99
Neuroprotective effect of the natural iron chelator, phytic acid in a cell culture model of Parkinson's disease. Toxicology (2007) 0.98
Protein targets of 1,4-benzoquinone and 1,4-naphthoquinone in human bronchial epithelial cells. Proteomics (2003) 0.96
Homogentisic acid autoxidation and oxygen radical generation: implications for the etiology of alkaptonuric arthritis. Free Radic Biol Med (1987) 0.94
Cysteinylation and homocysteinylation of plasma protein thiols during ageing of healthy human beings. J Cell Mol Med (2008) 0.92
Hereditary ceruloplasmin deficiency with hemosiderosis. Hum Genet (1996) 0.91
N-acetylcysteine prevents nitric oxide-induced chondrocyte apoptosis and cartilage degeneration in an experimental model of osteoarthritis. J Orthop Res (2010) 0.91
Effect of quinones on microtubule polymerization: a link between oxidative stress and cytoskeletal alterations in Alzheimer's disease. Biochim Biophys Acta (2004) 0.91
Determination of plasma thiol bound to albumin using affinity chromatography and high-performance liquid chromatography with fluorescence detection: ratio of cysteinyl albumin as a possible biomarker of oxidative stress. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.89
Alpha-lipoic acid suppresses the development of collagen-induced arthritis and protects against bone destruction in mice. Rheumatol Int (2006) 0.88
Plasma albumin cysteinylation is regulated by cystathionine beta-synthase. Biochem Biophys Res Commun (2004) 0.86
Characterization of a nonsense mutation in the ceruloplasmin gene resulting in diabetes and neurodegenerative disease. Hum Mol Genet (1996) 0.85
Alpha lipoic acid alleviates oxidative stress and preserves blood brain permeability in rats with subarachnoid hemorrhage. Neurochem Res (2009) 0.84
Modulation of cellular glutathione and protein thiol status during quinone metabolism. Methods Enzymol (1990) 0.84
Inhibition and activation of the oxidation of homogentisic acid. J Biol Chem (1953) 0.84
Attenuation of tamoxifen-induced hepatotoxicity by taurine in mice. Clin Chim Acta (2006) 0.83
Outcome of tyrosinaemia type III. J Inherit Metab Dis (2001) 0.83
Modification of ferritin during iron loading. Free Radic Biol Med (2001) 0.81
Adaptation of protein carbonyl detection to the requirements of proteome analysis demonstrated for hypoxia/reoxygenation in isolated rat liver mitochondria. Arch Biochem Biophys (2000) 0.81
Enhancement of DMNQ-induced hepatocyte toxicity by cytochrome P450 inhibition. Toxicol Appl Pharmacol (2006) 0.81
Homogentisic acid and structurally related compounds as intermediates in plasma soluble melanin formation and in tissue toxicities. Arch Int Physiol Biochim Biophys (1995) 0.80
Alkaptonuria. N Engl J Med (2003) 0.80
The role of cysteine residues in the oxidation of ferritin. Free Radic Biol Med (2002) 0.79
Stoichiometry of Fe(II) oxidation during ceruloplasmin-catalyzed loading of ferritin. Arch Biochem Biophys (1992) 0.79
Cytochrome P450 destruction by benzene metabolites 1,4-benzoquinone and 1,4-hydroquinone and the formation of hydroxyl radicals in minipig liver microsomes. Toxicol In Vitro (2006) 0.78
Aboard transthyretin: From transport to cleavage. IUBMB Life (2010) 0.78
Reaction of quinone of homogentisic acid with biological amines. Arthritis Rheum (1967) 0.77
Lipoic acid effects on lipid peroxidation level, superoxide dismutase activity and monoamines concentration in rat hippocampus. Neurosci Lett (2009) 0.76
Chondrocyte growth inhibition induced by homogentisic acid and its partial prevention with ascorbic acid. J Rheumatol (1989) 0.76
Quinoproteins. FASEB J (1994) 0.76
CLINICAL AND PATHOLOGICAL FINDINGS IN OCHRONOSIS. J Clin Pathol (1960) 0.75
Oscillatory oxido-reductive reaction of intracellular hemoglobin in human erythrocyte incubated with o-aminophenol. Tohoku J Exp Med (2000) 0.75
Multi-effective properties of homogentisic acid revealed in reactions with human hemoglobin and human erythrocytic hemoglobin. Int J Hematol (2000) 0.75
Effects of N-acetylcysteine, quercetin, and phytic acid on spontaneous hepatic and renal lesions in LEC rats. Toxicol Pathol (2005) 0.75
Extensive bluish gray skin pigmentation and severe arthropathy. Endogenous ochronosis (alkaptonuria). Arch Dermatol (2000) 0.75
Studies on ochronosis. I. The distribution of homogentisic acid in guinea pigs. Arthritis Rheum (1962) 0.75
Depletion of cellular protein thiols as an indicator of arylation in isolated trout hepatocytes exposed to 1,4-benzoquinone. Toxicol Sci (2000) 0.75
Studies of alcaptonuria: binding of homogentisic acid solutions to hide powder collagen. Proc Soc Exp Biol Med (1961) 0.75
Development of an in vitro model to investigate joint ochronosis in alkaptonuria. Rheumatology (Oxford) (2010) 1.28
Evaluation of anti-oxidant treatments in an in vitro model of alkaptonuric ochronosis. Rheumatology (Oxford) (2010) 1.11
Extragastric manifestations of Helicobacter pylori infection. Helicobacter (2010) 1.11
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer. Cancer (2009) 1.10
Alkaptonuria is a novel human secondary amyloidogenic disease. Biochim Biophys Acta (2012) 1.09
Biochemical investigation of the effects of human platelet releasates on human articular chondrocytes. J Cell Biochem (2009) 1.09
Evaluation of antioxidant drugs for the treatment of ochronotic alkaptonuria in an in vitro human cell model. J Cell Physiol (2010) 1.06
Antimicrobial activity against Helicobacter pylori strains and antioxidant properties of blackberry leaves (Rubus ulmifolius) and isolated compounds. Int J Antimicrob Agents (2009) 1.06
Homogentisate 1,2 dioxygenase is expressed in human osteoarticular cells: implications in alkaptonuria. J Cell Physiol (2012) 1.04
Proteomic and redox-proteomic evaluation of homogentisic acid and ascorbic acid effects on human articular chondrocytes. J Cell Biochem (2010) 1.03
Biochemical and proteomic characterization of alkaptonuric chondrocytes. J Cell Physiol (2012) 0.99
Vascular endothelial growth factor-D activates VEGFR-3 expressed in osteoblasts inducing their differentiation. J Biol Chem (2006) 0.99
Antioxidants inhibit SAA formation and pro-inflammatory cytokine release in a human cell model of alkaptonuria. Rheumatology (Oxford) (2013) 0.98
A proteomic study on human osteoblastic cells proliferation and differentiation. Proteomics (2006) 0.98
Bronchoalveolar lavage fluid protein composition in patients with sarcoidosis and idiopathic pulmonary fibrosis: a two-dimensional electrophoretic study. Electrophoresis (2002) 0.97
Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clin Transl Allergy (2012) 0.97
Proteomic response to physiological fermentation stresses in a wild-type wine strain of Saccharomyces cerevisiae. Biochem J (2003) 0.96
Comparative proteomics and immunoproteomics of Helicobacter pylori related to different gastric pathologies. J Chromatogr B Analyt Technol Biomed Life Sci (2006) 0.92
Proteome analysis of Neisseria meningitidis serogroup A. Proteomics (2004) 0.92
Sex-based differences in susceptibility to respiratory and systemic pneumococcal disease in mice. J Infect Dis (2011) 0.89
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells. FASEB J (2008) 0.88
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice. J Med Chem (2007) 0.87
CagA and VacA are immunoblot markers of past Helicobacter pylori infection in atrophic body gastritis. Helicobacter (2007) 0.87
Comparative analysis of the effects of locally used herbicides and their active ingredients on a wild-type wine Saccharomyces cerevisiae strain. J Agric Food Chem (2006) 0.86
Rapid aggregation and assembly in aqueous solution of A beta (25-35) peptide. J Biosci (2009) 0.85
Long-term effects of neridronate on human osteoblastic cell cultures. Bone (2004) 0.85
2-Hydroxypropyl-β-cyclodextrin strongly improves water solubility and anti-proliferative activity of pyrazolo[3,4-d]pyrimidines Src-Abl dual inhibitors. Eur J Med Chem (2010) 0.85
Western blotting of total lysate of Helicobacter pylori in cases of atrophic body gastritis. Clin Chem (2005) 0.84
Immonium ion scanning for the discovery of post-translational modifications and its application to histones. J Proteome Res (2008) 0.84
Post-genomics of bone metabolic dysfunctions and neoplasias. Proteomics (2012) 0.84
Amyloidosis in alkaptonuria. J Inherit Metab Dis (2015) 0.84
Characterization of plasma factors that alter the permeability to albumin within isolated glomeruli. Proteomics (2002) 0.83
Helicobacter pylori immunoproteomes in case reports of rosacea and chronic urticaria. Proteomics (2005) 0.83
Two-step elution of human serum proteins from different glass-modified bioactive surfaces: a comparative proteomic analysis of adsorption patterns. Electrophoresis (2004) 0.83
A branched peptide mimotope of the nicotinic receptor binding site is a potent synthetic antidote against the snake neurotoxin alpha-bungarotoxin. Biochemistry (2002) 0.82
The analysis of Neisseria meningitidis proteomes: Reference maps and their applications. Proteomics (2007) 0.82
Establishment and characterization of 4 new human pancreatic cancer cell lines: evidences of different tumor phenotypes. Pancreas (2009) 0.81
Postgenomics of Neisseria meningitidis: an update. Expert Rev Proteomics (2009) 0.81
The 10th anniversary of the Junior Members and Affiliates of the European Academy of Allergy and Clinical Immunology. Pediatr Allergy Immunol (2011) 0.81
Serum amyloid A circulating levels and disease activity in patients with juvenile idiopathic arthritis. Yonsei Med J (2012) 0.80
Different factors affecting human ANP amyloid aggregation and their implications in congestive heart failure. PLoS One (2011) 0.80
Proteomics and redox-proteomics of the effects of herbicides on a wild-type wine Saccharomyces cerevisiae strain. J Proteome Res (2009) 0.80
Postgenomics of Neisseria meningitidis for vaccines development. Expert Rev Proteomics (2007) 0.80
Linking protein oxidation to environmental pollutants: redox proteomic approaches. J Proteomics (2011) 0.79
Helicobacter pylori: immunoproteomics related to different pathologies. Expert Rev Proteomics (2007) 0.79
Chondroptosis in alkaptonuric cartilage. J Cell Physiol (2015) 0.78
Helicobacter pylori immunoproteomics in gastric cancer and gastritis of the carcinoma phenotype. Expert Rev Proteomics (2010) 0.78
Inactivation of Helicobacter pylori cagA gene affects motility. Helicobacter (2004) 0.78
In vivo 13C-NMR and modelling study of metabolic yield response to ethanol stress in a wild-type strain of Saccharomyces cerevisiae. FEBS Lett (2004) 0.78
Novel identification of expressed genes and functional classification of hypothetical proteins from Neisseria meningitidis serogroup A. Proteomics (2007) 0.78
High levels of maternal serum IL-17 and activin A in pregnant women affected by systemic lupus erythematosus. Am J Reprod Immunol (2011) 0.78
Small HDL form via apo A-I a complex with atrial natriuretic peptide. Biochem Biophys Res Commun (2004) 0.78
Oxidative damage mediated by herbicides on yeast cells. J Agric Food Chem (2008) 0.77
Mapping phosphoproteins in Neisseria meningitidis serogroup A. Proteomics (2011) 0.77